Lipogenex LLC Scottsdale, AZ - 85260

Lipogenex LLC is categorized under Physical Medicine, Physician/Surgeon in Scottsdale, AZ and active since 2008.

Lipogenex LLC was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Emmanouil Karampahtsis at the company’s single location by writing to 14300 North Northsight Boulevard, Scottsdale, Arizona AZ 85260 or by phoning (480) 664-2288. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lipogenex LLC
Contact Person: Emmanouil Karampahtsis
Address: 14300 North Northsight Boulevard, Scottsdale, Arizona 85260
Phone Number: (480) 664-2288
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physical Medicine, Physician/Surgeon
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Lipogenex LLC was started in 2008 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Emmanouil Karampahtsis for inquiries that concern Lipogenex LLC by calling the company number (480) 664-2288, as your correspondence is most welcome. Additionally, the physical location of the single location of Lipogenex LLC can be found at the coordinates 33.61598,-111.89788 as well as the street address 14300 North Northsight Boulevard in Scottsdale, Arizona 85260.

For its online presence, you may visit Lipogenex LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.